(Q63966029)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12711484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

Benign prostatic hyperplasia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12711484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

main subject

prostatic hypertrophy

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12711484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

A Thorpe

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12711484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12711484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12711484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

361

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12711484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

9366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12711484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1359-1367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12711484%20AND%20SRC:MED&resulttype=core&format=json

Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Future concepts in the medical therapy of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Induction of apoptosis in the prostate by alpha1-adrenoceptor antagonists: a novel effect of "old" drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Peptide growth factors in the prostate as mediators of stromal epithelial interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

High-risk group for benign prostatic hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Risk factors for surgically treatedbenign prostatic hyperplasia in a prepaid health care plan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

The development of human benign prostatic hyperplasia with age

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Etiology and disease process of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Health status and quality of life of British men with lower urinary tract symptoms: results from the SF-36.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Natural history of prostatism: impaired health states in men with lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

High prevalence of benign prostatic hypertrophy in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

The incidence of benign prostatic obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Just old age? A study of prostatism in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Benign prostatic hyperplasia. Universal problem among aging men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Deaths and complications following prostatectomy in 1400 men in the northern region of England. Northern Regional Prostate Audit Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

The management of men with acute urinary retention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

The outcome of prostatectomy on chronic retention of urine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Safety, efficacy and impact on Patients' quality of life of a long-term treatment with the alpha(1)-blocker alfuzosin in symptomatic patients with BPH. The Italian Alfuzosin Co-Operative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Watchful waiting or drug therapy for benign prostatic hyperplasia?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Use of symptom questionnaires in the assessment and follow-up of men with benign prostatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Nottingham health profile measurement in the assessment of clinical outcome after prostatectomy. Northern Regional Prostate Audit Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Relationships between lower urinary tract symptoms and bladder outlet obstruction: Results from the ICS-“BPH” Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Value of the Danish Prostate Symptom Score compared to the AUA symptom score and pressure/flow studies in the preoperative evaluation of men with symptomatic benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Natural history and epidemiology of benign prostatic hyperplasia: relationship among urologic measures.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Conventional Urodynamics and Ambulatory Monitoring in the Definition and Management of Bladder Outflow Obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Outcome of elective prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Management of benign prostatic hyperplasia in Scandinavia. A hospital questionnaire on pretreatment evaluation and treatment. The Scandinavian Urologic Association Subcommittee on Benign Prostatic Hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Relationship among age, prostate-specific antigen, and prostate volume in men with lower urinary tract symptoms (LUTS) and in different groups of men with and without benign and malignant prostate diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Medical outcomes research and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Comparison of therapies for lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Impact of medical therapy on transurethral resection of the prostate: a decade of change

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Medical therapy and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Alpha1-adrenoceptor subtypes in the human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Alpha adrenoceptor antagonists in the year 2000: is there anything new?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Medical therapy for benign prostatic hyperplasia: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. European ALFIN Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Medical therapy for benign prostatic hyperplasia progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

An aid for hemostasis in open prostatectomy: capsular plication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Improved hemostasis during simple retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

A population-based study of prostatectomy: outcomes associated with differing surgical approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

The effect of prostatectomy on symptom severity and quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Holmium:yttrium-aluminum-garnet laser prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

A 12-month study of the placebo effect in transurethral microwave thermotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

High energy thermotherapy versus transurethral resection in the treatment of benign prostatic hyperplasia: results of a prospective randomized study with 1 year of followup.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

A cost-effectiveness analysis of transurethral resection of the prostate and transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: two-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: early clinical experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Invasive and minimally invasive treatment modalities for lower urinary tract symptoms: what are the relevant differences in randomised controlled trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

High-intensity focused ultrasound energy for benign prostatic hyperplasia: clinical response at 6 months to treatment using Sonablate 200.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

High-intensity focused ultrasound in the treatment of benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

The urodynamic impact of transrectal high-intensity focused ultrasound on bladder outflow obstruction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Two-year results of transurethral resection of the prostate versus four 'less invasive' treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Evaluation of transurethral vaporization of prostate with pressure-flow analysis and other clinical measures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

Outcome of vaportrode transurethral vaporization of the prostate using pressure-flow urodynamic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913073-5

7 January 2021

10.1016/S0140-6736(03)13073-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12711484%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference